Anzeige
Meldung des Tages: DiagnosTear Technologies: Technologischer Geniestreich für die Massen!

Ad-hocs

25.11.25 - GlobeNewswire
Volta Finance Limited Net Asset Value(s) as at 31 October 2025
Volta Finance Limited (VTA / VTAS) October 2025 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES
25.11.25 - GlobeNewswire
Golar LNG announces successful completion of $1.2BN FLNG Gimi bank facility
Golar LNG Limited (“Golar”) is pleased to announce that it has successfully closed and drawn a new $1.2 billion asset backed debt facility agreement with a consortium of banks ...
25.11.25 - EQS
EQS-Adhoc: JENOPTIK AG: Dr. Stefan Traeger verlässt Jenoptik
EQS-​Ad-hoc: JENOPTIK AG / Schlagwort(e): Personalie JENOPTIK AG: Dr. Stefan Traeger verlässt Jenoptik 25.11.2025 / 13:54 CET/CEST Veröffentlichung einer Insiderinformation ...
25.11.25 - EQS
EQS-Adhoc: RheinLand Holding AG: Anpassung der Prognose für das Konzernergebnis 2025
EQS-​Ad-hoc: RheinLand Holding AG / Schlagwort(e): Prognoseänderung RheinLand Holding AG: Anpassung der Prognose für das Konzernergebnis 2025 25.11.2025 / 13:46 ...
25.11.25 - GlobeNewswire
Nokia announces delisting from Paris Stock Exchange
Nokia Corporation Stock Exchange Release 25 November 2025 at 13:30 EET Nokia announces delisting from Paris Stock Exchange
25.11.25 - GlobeNewswire
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeks Amycretin demonstrated statistically significant reductions in HbA 1c with up to 89.1% achieving ...
25.11.25 - EQS
EQS-Adhoc: ecotel communication ag: Anpassung der Prognose zum Konzernüberschuss für das Geschäftsjahr 2025 aufgrund Bildung einer Steuerrückstellung in Höhe von EUR 2,8 Mio.
EQS-​Ad-hoc: ecotel communication ag / Schlagwort(e): Prognoseänderung/Jahresergebnis ecotel communication ag: Anpassung der Prognose zum Konzernüberschuss für das ...
25.11.25 - EQS
Notification of a manager’s transaction.
Reinet Investments SCA / Key word(s): Miscellaneous Notification of a manager’s transaction. 25-Nov-2025 / 12:00 CET/CEST Release of an ad hoc announcement pursuant to Art. ...
25.11.25 - EQS
EQS-Adhoc: Pyrum Innovations AG beschließt Bezugsrechtskapitalerhöhung gegen Bareinlagen aus genehmigtem Kapital im Umfang von bis zu EUR 21 Millionen
EQS-​Ad-hoc: Pyrum Innovations AG / Schlagwort(e): Kapital­erhöhung Pyrum Innovations AG beschließt Bezugsrechtskapitalerhöhung gegen Bareinlagen aus genehmigtem Kapital ...
25.11.25 - GlobeNewswire
Progress on share buyback programme
Progress on share buyback programme
25.11.25 - GlobeNewswire
ABN AMRO to sell Alfam to Rabobank
ABN AMRO to sell Alfam to Rabobank Personal loans offered via a third-​party arrangement 25 November 2025 Today, ABN AMRO announces that it has reached an agreement on ...
25.11.25 - EQS
Straumann Group präsentiert mittelfristige Wachstumsstrategie für mehr Marktanteile, höhere Profitabilität und stärkeren Cashflow
Straumann Holding AG / Schlagwort(e): Konferenz/Strategische Unternehmensentscheidung Straumann Group präsentiert mittelfristige Wachstumsstrategie für mehr Marktanteile, ...
25.11.25 - EQS
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics Holding SA / Key word(s): Mergers & Acquisitions Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated ...
25.11.25 - GlobeNewswire
ABN AMRO presents roadmap for profitable growth and new financial targets for 2028
ABN AMRO presents roadmap for profitable growth and new financial targets for 2028
25.11.25 - GlobeNewswire
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing ...
25.11.25 - GlobeNewswire
Weekly progress on share repurchase program to cover share plans and reduce capital
Press Release
25.11.25 - GlobeNewswire
Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
25.11.25 - EQS
EPIC Suisse releases high level Q3 2025 numbers in line with majority shareholder's reporting obligations
EPIC Suisse AG / Key word(s): Quarter Results EPIC Suisse releases high level Q3 2025 numbers in line with majority shareholder's reporting obligations 25-Nov-2025 / 06:45 ...
24.11.25 - GlobeNewswire
PRESS RELEASE: BIGBEN: HALF-YEAR RESULTS 2025-2026 - ENGLISH VERSION
Press release
24.11.25 - GlobeNewswire
PRESS RELEASE: NACON: HALF-YEAR RESULTS 2025-2026 - ENGLISH VERSION
Press Release

Newssuche

News zu allen Indizes

Videos

newspaper
16.12.25 +1,32%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »